Events

We believe in building a strong community and sharing knowledge. That's why we host a variety of events, workshops, and training sessions throughout the year. We also attend numerous conferences, and we'd love to connect with you there!

Upcoming workshops

Dr-Niclas-Jonsson-presenting-on-FREM-UPSS-Pharmetheus-scaled

PAGE 2026 workshop: Mastering covariate modeling – hands-on with the Full Random Effects Model (FREM) approach

Join us for an interactive one-day workshop, June 2, in connection with PAGE 2026. This workshop dives deep into the Full Random Effects Model (FREM) methodology.

Learn more and sign up
Erik Sjögren leading a workshop at PAGE

Workshop at PAGE 2026: PBPK & PBBM – linking biopharmaceutics to clinical performance with OSP suite

Join this workshop on using and leveraging the Open Systems Pharmacology (OSP) suite to link biopharmaceutics properties to clinical performance and address formulation-related questions throughout drug development.

Learn more and sign up

Upcoming events

Join us at PAGE 2-5 June in Dubrovnik, Croatia. Visit the Pharmetheus booth to meet our passionate team, explore our latest offerings, and discuss exciting opportunities. Find out who from our team will be attending and take part in our scientific contributions during the event.

Complimentary advisory sessions tailored to provide expert guidance and support, regardless of geographical constraints, to help you succeed in your academic journey.

Past events

We will be attending the 1st International PBPK Conference in Basel, Switzerland on April 21-24, 2026. Are you interested in learning more about PBPK? Join one of our workshop, held by Pharmetheus PBPK & PBBM experts.

Webinar series

This webinar series provides an introduction to model-informed bioequivalence, including its potential and limitations. You’ll gain an understanding of the techniques Physiologically-Based Biopharmaceutics Modeling (PBBM) for virtual bioequivalence and Non-Linear Mixed-Effects Modeling (NLME) for model-based bioequivalence (MBBE), and how they are transforming approaches to drug development and regulatory submissions.

Get in touch